investor.sophirisbio.com
Sophiris Bio Inc. - Shareholder Tools
http://investor.sophirisbio.com/tools.cfm
Prostate cancer program overview. Events & presentations. Collect, save and zip multiple files for fast download and email, or bookmark your favorite files for a later visit to the IR website. Order printed documents to be sent to you by mail, or view a history of the documents you have previously requested. Find exactly the file(s) you need. Send files directly into your Shareholder Briefcase, or download individual files. Download a synopsis of the most recent content within our IR website.
investor.sophirisbio.com
Sophiris Bio Reports Third Quarter 2016 Financial Results and Key Business Highlights (NASDAQ:SPHS)
http://investor.sophirisbio.com/releasedetail.cfm?ReleaseID=998600
Laquo; Previous Release. Next Release ». November 9, 2016. Sophiris Bio Reports Third Quarter 2016 Financial Results and Key Business Highlights. VANCOUVER, British Columbia. Nov 9, 2016. The "Company" or "Sophiris"), a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases, today announced financial results for the three and nine months ended. September 30, 2016. August 26, 2016. During the third quarter of 2016, the Company received proceeds of. We had cash, c...
investor.sophirisbio.com
Sophiris Bio Inc. - Financial Information
http://investor.sophirisbio.com/sec.cfm
Prostate cancer program overview. Events & presentations. Amended statement of beneficial ownership. Feb 14, 2017. Amended statement of beneficial ownership. Feb 14, 2017. Amended statement of beneficial ownership. Feb 10, 2017. Feb 8, 2017. Feb 8, 2017. Feb 8, 2017. Amended statement of beneficial ownership. Jan 30, 2017. Amended statement of beneficial ownership. Jan 11, 2017. Dec 21, 2016. Slover, peter t. Dec 9, 2016. Dec 9, 2016. Woods, randall e. Dec 9, 2016. Dec 9, 2016. Nov 9, 2016. Nov 9, 2016.
investor.sophirisbio.com
Sophiris Bio Inc. - Events & Presentations
http://investor.sophirisbio.com/events.cfm
Prostate cancer program overview. Events & presentations. Download the Sophiris Investor Presentation. Jun 9, 2016. Sophiris Phase 2a Prostate Cancer Data Investor Webcast. May 7, 2016. Topsalysin Phase 3 Data from Positive Plus-1 Study as a Late Breaking Poster during the 111th American Urological Association Annual Meeting. Jan 28, 2016. Sophiris Investor Webcast: Review of Topsalysin Clinical Data. Mar 13, 2017. 29th Annual ROTH Conference. Please sign up for email alert notification. Feb 2, 2017.
investor.sophirisbio.com
Sophiris Bio Inc. - Stock Information
http://investor.sophirisbio.com/stockquote.cfm
Prostate cancer program overview. Events & presentations. Sophiris Bio Inc. (NASDAQ: SPHS). 4:00 PM ET on Mar 10, 2017. 007 - (2.81%). Convert chart to Excel. Sign up for email alerts.